Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

ClinicalTrials.gov ID: NCT01977573

Public ClinicalTrials.gov record NCT01977573. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 24-week, Phase IIB, Randomized, Controlled, Parallel Group, Multi-center Study to Evaluate the Safety and Efficacy of GSK1278863 in Subjects With Anemia Associated With Chronic Kidney Diseases Who Are Not on Dialysis.

Study identification

NCT ID
NCT01977573
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
252 participants

Conditions and interventions

Conditions

Interventions

  • GSK1278863 Drug
  • rhEPO Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 30, 2013
Primary completion
Apr 30, 2015
Completion
Jun 14, 2015
Last update posted
Oct 11, 2018

2013 – 2015

United States locations

U.S. sites
25
U.S. states
12
U.S. cities
24
Facility City State ZIP Site status
GSK Investigational Site Peoria Arizona 85381
GSK Investigational Site Azusa California 91702
GSK Investigational Site La Mesa California 91942
GSK Investigational Site Laguna Hills California 92653
GSK Investigational Site Los Angeles California 90022
GSK Investigational Site Los Angeles California 90025
GSK Investigational Site San Diego California 92103
GSK Investigational Site San Dimas California 91773
GSK Investigational Site West Hills California 91307
GSK Investigational Site Lauderdale Lakes Florida 33313
GSK Investigational Site Miami Florida 33150
GSK Investigational Site Pembroke Pines Florida 33028
GSK Investigational Site Macon Georgia 31217
GSK Investigational Site Savannah Georgia 31406
GSK Investigational Site Evergreen Park Illinois 60805
GSK Investigational Site Shreveport Louisiana 71101
GSK Investigational Site Farmington Missouri 63640
GSK Investigational Site Charlotte North Carolina
GSK Investigational Site Bethlehem Pennsylvania 18017
GSK Investigational Site Uniontown Pennsylvania 15401
GSK Investigational Site Knoxville Tennessee 37923
GSK Investigational Site Corsicana Texas 75110
GSK Investigational Site San Antonio Texas 78229
GSK Investigational Site Temple Texas 76508
GSK Investigational Site Salt Lake City Utah 84112

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01977573, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 11, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01977573 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →